Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
M1389 MarkerGene™ Cellular Senescence Assay Kit, Can be used to monitor and detect â galactosidase activity in senescent cells at pH 6.0 using X Gal, 1 kit MarkerGene 317 M1389 MarkerGene™ Cellular Senescence Assay Kit, Can be used to monitor and detect â galactosidase activity in senescent cells at pH 6.0 using X Gal, 1 kit MarkerGene 317
ASK
Publication
M1405 MarkerGene™ Cellular Senescence Microtiterplate Assay Kit, This kit uses the high sensitivity substrate fluorescein di â D galactopyranoside (FDG) to quantify senescent cells, 1 kit MarkerGene 316 M1405 MarkerGene™ Cellular Senescence Microtiterplate Assay Kit, This kit uses the high sensitivity substrate fluorescein di â D galactopyranoside (FDG) to quantify senescent cells, 1 kit MarkerGene 316
ASK
Publication
A-2040-3 MyGenie 96 Gradient Thermal Block, with TCP IP Protocol Bioneer 1 10180 A-2040-3 MyGenie 96 Gradient Thermal Block, with TCP IP Protocol Bioneer 1 10180 Publication
K320-250 Senescence Detection Kit Biovision 250 Stainings 328 K320-250 Senescence Detection Kit Biovision 250 Stainings 328
ASK
Publication
1758-100 Resveratrol Biovision 100 mg 104 1758-100 Resveratrol Biovision 100 mg 104 Publication
1758-500 Resveratrol Biovision 500 mg 250 1758-500 Resveratrol Biovision 500 mg 250 Publication
M57735199 Resveratrol CAS Number [501 36 0] Molekula 1 G 135 M57735199 Resveratrol CAS Number [501 36 0] Molekula 1 G 135
ASK
Publication
A965120 Azo-Resveratrol C12H10N2O3 CAS: 1393556-48-3 TRC 10 mg 245 A965120 Azo-Resveratrol C12H10N2O3 CAS: 1393556-48-3 TRC 10 mg 245
ASK
Publication
305-13451 Anti 3 DG imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sev B-Bridge 50 UG 958.65 305-13451 Anti 3 DG imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sev B-Bridge 50 UG 958.65
ASK
Publication
SP1800 Syringe pump can be controlled manually or with a computer. Good for infusion, withdrawal or up to 41 programable pumping phases. Stall detection. Allows pumping of 8 syringes at a time. Next Advence 1610 SP1800 Syringe pump can be controlled manually or with a computer. Good for infusion, withdrawal or up to 41 programable pumping phases. Stall detection. Allows pumping of 8 syringes at a time. Next Advence 1610 Publication
DS-01-0271 Native Human Kininogen HMW Double Chain Ray Biotech 100 422 DS-01-0271 Native Human Kininogen HMW Double Chain Ray Biotech 100 422
ASK
Publication
A187690 4’-O-Acetyl cis Resveratrol 3-O-β-D-Glucuronide Methyl Ester Triacetate C29H30O13 CAS: TRC 2.5 mg 232 A187690 4’-O-Acetyl cis Resveratrol 3-O-β-D-Glucuronide Methyl Ester Triacetate C29H30O13 CAS: TRC 2.5 mg 232
ASK
Publication
ELDT-100 EnzyLight™ ADP ATP Ratio Assay Kit Bioassays 100 317 ELDT-100 EnzyLight™ ADP ATP Ratio Assay Kit Bioassays 100 317 Publication
IHPLA-SC-PREN Human Renin Prorenin double Depleted Plasma Innovative Research INC 1.0ml 382 IHPLA-SC-PREN Human Renin Prorenin double Depleted Plasma Innovative Research INC 1.0ml 382 Publication
IHPLA-SC-PREN-1.0ml Human Renin Prorenin double Depleted Plasma 1.0 ml Innovative Research INC 401 IHPLA-SC-PREN-1.0ml Human Renin Prorenin double Depleted Plasma 1.0 ml Innovative Research INC 401
ASK
Publication
K255-200 ApoSENSOR™ ADP ATP Ratio Assay Kit Biovision 200 assays 546 K255-200 ApoSENSOR™ ADP ATP Ratio Assay Kit Biovision 200 assays 546 Publication
K255-200 ADP/ATP Ratio Assay Kit, ApoSENSOR Biovision 200 assays 546.21 K255-200 ADP/ATP Ratio Assay Kit, ApoSENSOR Biovision 200 assays 546.21 Publication
4418-APC-100 H2AX Phosphorylated Histone Double Affinity Purified Antibody Trevigen 100 ul 377 4418-APC-100 H2AX Phosphorylated Histone Double Affinity Purified Antibody Trevigen 100 ul 377 Publication
STA-326 OxiSelect™ Cellular UV-Induced DNA Damage ELISA Kit (CPD) Cell Biolabs 96 assays 489 STA-326 OxiSelect™ Cellular UV-Induced DNA Damage ELISA Kit (CPD) Cell Biolabs 96 assays 489 Publication
S2025-D-B-230V* ProBlot Rocker 25D with double platform (26 x 20 cm), 230V*, includes EU and UK power cords Labnet International Inc. 690 S2025-D-B-230V* ProBlot Rocker 25D with double platform (26 x 20 cm), 230V*, includes EU and UK power cords Labnet International Inc. 690
ASK
Publication
MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88 MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88
ASK
Publication
15263 Amplite™ Fluorimetric NAD NADH Ratio Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 319 15263 Amplite™ Fluorimetric NAD NADH Ratio Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 319
ASK
Publication
A672500 3-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile, Mixture of double bond isomers C19H20N2O3 CAS: 30078-48-9 TRC 1 g 206 A672500 3-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile, Mixture of double bond isomers C19H20N2O3 CAS: 30078-48-9 TRC 1 g 206
ASK
Publication
15264 Amplite™ Fluorimetric NADP NADPH Ratio Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 319 15264 Amplite™ Fluorimetric NADP NADPH Ratio Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 319
ASK
Publication
10056 Amplite™ Fluorimetric Glutathione GSH GSSG Ratio Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 180 10056 Amplite™ Fluorimetric Glutathione GSH GSSG Ratio Assay Kit *Red Fluorescence* AAT Bioquest 1 kit 180
ASK
Publication
10056 Amplite™ Fluorimetric Glutathione GSH GSSG Ratio Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 280 10056 Amplite™ Fluorimetric Glutathione GSH GSSG Ratio Assay Kit *Green Fluorescence* AAT Bioquest 1 kit 280
ASK
Publication
STPT Stabil PAC Trial (1 x 10 mg Nvoy Polymer) Expedeon 89.25 STPT Stabil PAC Trial (1 x 10 mg Nvoy Polymer) Expedeon 89.25
ASK
Publication
M1622 OliGloTM Cy3 FISH Kit trial size MarkerGene 374 M1622 OliGloTM Cy3 FISH Kit trial size MarkerGene 374
ASK
Publication
M1620 OliGloTM TAMRA FISH Kit trial size MarkerGene 374 M1620 OliGloTM TAMRA FISH Kit trial size MarkerGene 374
ASK
Publication
30029-T NUC VIEW 488 CASPASE 3 ASSAY KIT, TRIAL SIZE Biotium 1 ST 174.216 30029-T NUC VIEW 488 CASPASE 3 ASSAY KIT, TRIAL SIZE Biotium 1 ST 174.216
ASK
Publication
HTK-05 Hemo Trial Kit™ Biotech support group 5 ml Hemoglobind ,5 Preps of Hemovoid 355 HTK-05 Hemo Trial Kit™ Biotech support group 5 ml Hemoglobind ,5 Preps of Hemovoid 355 Publication
M1624 OliGloTM Biotin FISH Kit trial size MarkerGene 374 M1624 OliGloTM Biotin FISH Kit trial size MarkerGene 374
ASK
Publication
102164 REASTAIN® Quick Diff Kit Ready to use kit for differential staining of cellular elements in peripheral blood smears Reagena 3x 500 ml 150 102164 REASTAIN® Quick Diff Kit Ready to use kit for differential staining of cellular elements in peripheral blood smears Reagena 3x 500 ml 150 Publication
KOG-200TE New 8 OHdG Check ELISA Trial Package (32wells) JaICA 32 wells 439 KOG-200TE New 8 OHdG Check ELISA Trial Package (32wells) JaICA 32 wells 439
ASK
Publication
M1602 OliGloTM Cy3 Universal Nucleic Acid Labeling Kit trial size MarkerGene 281 M1602 OliGloTM Cy3 Universal Nucleic Acid Labeling Kit trial size MarkerGene 281
ASK
Publication
M1604 OliGloTM Biotin Universal Nucleic Acid Labeling Kit trial size MarkerGene 281 M1604 OliGloTM Biotin Universal Nucleic Acid Labeling Kit trial size MarkerGene 281
ASK
Publication
M1600 OliGloTM TAMRA Universal Nucleic Acid Labeling Kit trial size MarkerGene 281 M1600 OliGloTM TAMRA Universal Nucleic Acid Labeling Kit trial size MarkerGene 281
ASK
Publication
41005-T GelGreen Nucleic Acid Stain, 10,000X in water (trial size) Biotium 0,1 ML 81.9 41005-T GelGreen Nucleic Acid Stain, 10,000X in water (trial size) Biotium 0,1 ML 81.9
ASK
Publication
41003-T GelRed Nucleic Acid Stain, 10,000X in water (trial size) Biotium 0,1 ML 85 41003-T GelRed Nucleic Acid Stain, 10,000X in water (trial size) Biotium 0,1 ML 85
ASK
Publication
TE-0001 Transcription factors: NF-kB p65 ELISA Kit Signosis 2011 96 565 TE-0001 Transcription factors: NF-kB p65 ELISA Kit Signosis 2011 96 565 Publication
000788A mThomson Factors Polycistronic ABM Goods 250ul 3321 000788A mThomson Factors Polycistronic ABM Goods 250ul 3321
ASK
Publication
IHFVIIa Contact Factors: Human Factor VIIa Innovative Research INC 0.1mg 382 IHFVIIa Contact Factors: Human Factor VIIa Innovative Research INC 0.1mg 382 Publication
FA-0001 Transcription Factors: NFkB Filter Assay Signosis 2011 96 449 FA-0001 Transcription Factors: NFkB Filter Assay Signosis 2011 96 449 Publication
IHFXai Contact Factors: Human Factor Xab gla domainles Innovative Research INC 1mg 707 IHFXai Contact Factors: Human Factor Xab gla domainles Innovative Research INC 1mg 707 Publication
G360 UbC Promoter Yamanaka Factors Lentivirus Set ABM Goods 5 x 200ul 1908 G360 UbC Promoter Yamanaka Factors Lentivirus Set ABM Goods 5 x 200ul 1908
ASK
Publication
FA-0010 Transcription Factors: TF Filter Plate Assays Signosis 2011 96 368 FA-0010 Transcription Factors: TF Filter Plate Assays Signosis 2011 96 368 Publication
IHFX Contact Factors: Human Factor X Innovative Research INC 100 units 409 IHFX Contact Factors: Human Factor X Innovative Research INC 100 units 409 Publication
M1193 MarkerGeneTM Gaussia Luciferase Cellular Assay Kit, Utilizes a new luciferase which does not require ATP and can be expressed in mammalian cells using commercially available reporter plasmids, 1 kit MarkerGene 140 M1193 MarkerGeneTM Gaussia Luciferase Cellular Assay Kit, Utilizes a new luciferase which does not require ATP and can be expressed in mammalian cells using commercially available reporter plasmids, 1 kit MarkerGene 140
ASK
Publication
E01A0003 Human Angiopoietin Growth Factors ELISA KIT Other suppliers 96 Tests/kit 761.25 E01A0003 Human Angiopoietin Growth Factors ELISA KIT Other suppliers 96 Tests/kit 761.25 Publication
IHPT Contact Factors: Human Prothrombin (Factor II) Innovative Research INC 100 units 232 IHPT Contact Factors: Human Prothrombin (Factor II) Innovative Research INC 100 units 232 Publication
G361 EF1α Promoter Yamanaka Factors Lentivirus Set ABM Goods 5 x 200ul 898 G361 EF1α Promoter Yamanaka Factors Lentivirus Set ABM Goods 5 x 200ul 898
ASK
Publication
IHFXa Contact Factors: Human Factor Xa Inactivate Innovative Research INC 100 units 619 IHFXa Contact Factors: Human Factor Xa Inactivate Innovative Research INC 100 units 619 Publication
IHFXIII Contact Factors: Human coagulation Factor XIII Innovative Research INC 0.25mg 453 IHFXIII Contact Factors: Human coagulation Factor XIII Innovative Research INC 0.25mg 453 Publication
IHFXIIab Contact Factors: Human coagulation Factor beta-XIIa Innovative Research INC 0.1mg 382 IHFXIIab Contact Factors: Human coagulation Factor beta-XIIa Innovative Research INC 0.1mg 382 Publication
IHFIXA-FL-INFFR Contact Factors: Human Factor IXa, Active Site Labeled with Fluorescein Innovative Research INC 0.1mg 492 IHFIXA-FL-INFFR Contact Factors: Human Factor IXa, Active Site Labeled with Fluorescein Innovative Research INC 0.1mg 492 Publication
IHaT Contact Factors: Human alpha-Thrombin (Factor IIa) Innovative Research INC 1000 units 166 IHaT Contact Factors: Human alpha-Thrombin (Factor IIa) Innovative Research INC 1000 units 166 Publication
FA-1005 Transcription factors: Oxidative Stress TF Activation Profiling Plate Array Signosis 2011 6 595 FA-1005 Transcription factors: Oxidative Stress TF Activation Profiling Plate Array Signosis 2011 6 595 Publication
00178-V HIV type O envelope antigen. Synthetic HIV type O peptide, containing the HIV type O envelope derived sequence. Virogen 100 µg 280 00178-V HIV type O envelope antigen. Synthetic HIV type O peptide, containing the HIV type O envelope derived sequence. Virogen 100 µg 280
ASK
Publication
CQLD-100 QuantiChrom™ LDH Cytotoxicity Assay Kit, Quantitative determination of cytotoxicity based on cellular lactate dehydrogenase release into cell culture medium by colorimetric (565nm) method. Procedure Bioassays 100tests 113 CQLD-100 QuantiChrom™ LDH Cytotoxicity Assay Kit, Quantitative determination of cytotoxicity based on cellular lactate dehydrogenase release into cell culture medium by colorimetric (565nm) method. Procedure Bioassays 100tests 113 Publication
900100 Expression Systems OET 1 each 73.647 900100 Expression Systems OET 1 each 73.647
ASK
Publication
A113 Cre Expression Plasmid 706-Cre;tet Gene Bridges 0.2ug/ul,20ul 381 A113 Cre Expression Plasmid 706-Cre;tet Gene Bridges 0.2ug/ul,20ul 381 Publication
A112 Cre Expression Plasmid 705-Cre;cm Gene Bridges 0.2ug/ul,20ul 381 A112 Cre Expression Plasmid 705-Cre;cm Gene Bridges 0.2ug/ul,20ul 381 Publication
400100 baculoCOMPLETE protein expression kit OET 5 reactions 731.509 400100 baculoCOMPLETE protein expression kit OET 5 reactions 731.509 Publication
LY11280a CGB5 Over expression Lysate Abgent 100ug 462 LY11280a CGB5 Over expression Lysate Abgent 100ug 462
ASK
Publication
ABP-RVK-10002 Gryphon™ Retroviral Expression System II Allele Biotech 1 set 1148 ABP-RVK-10002 Gryphon™ Retroviral Expression System II Allele Biotech 1 set 1148 Publication
MMU-MIR-122 miRNASelect™ pEGP mmu mir 122 Expression Vector Cell Biolabs 100 µL 599 MMU-MIR-122 miRNASelect™ pEGP mmu mir 122 Expression Vector Cell Biolabs 100 µL 599
ASK
Publication
0149-35 Expression Media Products: ACES™ pAES35 AthenaES - GENIE Products 159 0149-35 Expression Media Products: ACES™ pAES35 AthenaES - GENIE Products 159
ASK
Publication
0149-30 Expression Media Products: ACES™ pAES30 AthenaES - GENIE Products 159 0149-30 Expression Media Products: ACES™ pAES30 AthenaES - GENIE Products 159
ASK
Publication
K-7250 AccuRapid™ Cell Free Protein Expression Kit Bioneer 24 reactions 694 K-7250 AccuRapid™ Cell Free Protein Expression Kit Bioneer 24 reactions 694 Publication
FYY203-5MG pYLEX1 - Expression Vector Gene Cloning Products Yeastern Biotech 5 μg 672 FYY203-5MG pYLEX1 - Expression Vector Gene Cloning Products Yeastern Biotech 5 μg 672
ASK
Publication
M0951 pCMVbeta Mammalian lacZ Expression Vector, 20micrograms MarkerGene 208 M0951 pCMVbeta Mammalian lacZ Expression Vector, 20micrograms MarkerGene 208
ASK
Publication
AP-1181 Gene Expression: Rat P450 cDNA Plate Array Signosis 2011 4 422 AP-1181 Gene Expression: Rat P450 cDNA Plate Array Signosis 2011 4 422 Publication
M1018 pSV40beta Mammalian lacZnls12co Expression Vector, 20micrograms MarkerGene 388 M1018 pSV40beta Mammalian lacZnls12co Expression Vector, 20micrograms MarkerGene 388 Publication
M1017 pCMVbeta Mammalian lacZnls12co Expression Vector, 20micrograms MarkerGene 388 M1017 pCMVbeta Mammalian lacZnls12co Expression Vector, 20micrograms MarkerGene 388
ASK
Publication
0148-2 Expression Media Products: ACES™ Signal Sequence Kit AthenaES - GENIE Products 268 0148-2 Expression Media Products: ACES™ Signal Sequence Kit AthenaES - GENIE Products 268
ASK
Publication
M1016 pSV40beta Mammalian lacZco Expression Vector, 20micrograms MarkerGene 372 M1016 pSV40beta Mammalian lacZco Expression Vector, 20micrograms MarkerGene 372
ASK
Publication
M1015 pCMVbeta Mammalian lacZco Expression Vector, 20micrograms MarkerGene 372 M1015 pCMVbeta Mammalian lacZco Expression Vector, 20micrograms MarkerGene 372
ASK
Publication
M0952 pSV40beta Mammalian lacZ Expression Vector, 20micrograms MarkerGene 208 M0952 pSV40beta Mammalian lacZ Expression Vector, 20micrograms MarkerGene 208
ASK
Publication
SI505VA-1 pGreenPuro shRNA expression lentivector (CMV) [packaged virus] SBI >1 x 10^6 IFUs 559 SI505VA-1 pGreenPuro shRNA expression lentivector (CMV) [packaged virus] SBI >1 x 10^6 IFUs 559
ASK
Publication
M1356 MarkerGene™ Biotin Detection and Quantitation Kit, Allows the measurement of the molar ratio of biotin to protein in biotin protein conjugates, biotin DNA molar ratios in biotinylated DNA samples, or MarkerGene 200 M1356 MarkerGene™ Biotin Detection and Quantitation Kit, Allows the measurement of the molar ratio of biotin to protein in biotin protein conjugates, biotin DNA molar ratios in biotinylated DNA samples, or MarkerGene 200
ASK
Publication
CD527A-1 Lentiviral Technology pCDH-EF1-MCS-T2A-Puro cDNA Cloning and Expression Vector 10 ug SBI 10 ug 515 CD527A-1 Lentiviral Technology pCDH-EF1-MCS-T2A-Puro cDNA Cloning and Expression Vector 10 ug SBI 10 ug 515
ASK
Publication
AP-1101 Gene Expression: Mouse NFkB-Regulated cDNA Plate Array Signosis 2011 4 422 AP-1101 Gene Expression: Mouse NFkB-Regulated cDNA Plate Array Signosis 2011 4 422
ASK
Publication
M1327 pCdgCAT Mammalian CAT Expression Vector, expresses the E. coli Chloramphenicol Acetyltransferase (CAT) gene, 20 micrograms MarkerGene 178 M1327 pCdgCAT Mammalian CAT Expression Vector, expresses the E. coli Chloramphenicol Acetyltransferase (CAT) gene, 20 micrograms MarkerGene 178
ASK
Publication
IQ289 Mouse AntiCytokeratin (keratin) type II, AE3 Target Antigen Cytokeratin (keratin) type II (AE3) Host Isotype Mouse IgG1 Application EM; IB; IHC (P) Imunquest 0.2ml 492 IQ289 Mouse AntiCytokeratin (keratin) type II, AE3 Target Antigen Cytokeratin (keratin) type II (AE3) Host Isotype Mouse IgG1 Application EM; IB; IHC (P) Imunquest 0.2ml 492
ASK
Publication
IQ288 Mouse AntiCytokeratin (keratin) type I (AE1) Target Antigen Cytokeratin (keratin) type I ( AE1) Host Isotype Mouse IgG1 Application EM; IB; IHC(P) Imunquest 0.2ml 492 IQ288 Mouse AntiCytokeratin (keratin) type I (AE1) Target Antigen Cytokeratin (keratin) type I ( AE1) Host Isotype Mouse IgG1 Application EM; IB; IHC(P) Imunquest 0.2ml 492
ASK
Publication
SPR-131C Recombinant Mn SOD (Human) Protein, his tagged Species Human Expression system E. coli Stressmarq 2x 100ug 1278 SPR-131C Recombinant Mn SOD (Human) Protein, his tagged Species Human Expression system E. coli Stressmarq 2x 100ug 1278
ASK
Publication
M1390 pNosdcGUS Plant GUS Expression Vector, This vector may be used to monitor virus production and transfection efficiency, 20 micrograms MarkerGene 362 M1390 pNosdcGUS Plant GUS Expression Vector, This vector may be used to monitor virus production and transfection efficiency, 20 micrograms MarkerGene 362
ASK
Publication
10-201 DNA (cytosine 5) methyltransferase 1 (Dnmt1), Active DNA methylation is significant for epigenetic regulation of gene expression, X chromosome inactivation, genomic imprinting, and development. Abber B-Bridge 300 units 363.3 10-201 DNA (cytosine 5) methyltransferase 1 (Dnmt1), Active DNA methylation is significant for epigenetic regulation of gene expression, X chromosome inactivation, genomic imprinting, and development. Abber B-Bridge 300 units 363.3
ASK
Publication
MOLBIO-SERV Molecular & Cellular Biology Services Molecular Biology Services Ray Biotech 0 MOLBIO-SERV Molecular & Cellular Biology Services Molecular Biology Services Ray Biotech 0
ASK
Publication
AA0101 Angiogenesis (Human) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 1416 AA0101 Angiogenesis (Human) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 1416
ASK
Publication
AA0100 Angiogenesis (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 1416 AA0100 Angiogenesis (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 1416
ASK
Publication
AA0099 Angiogenesis (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 754 AA0099 Angiogenesis (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 754
ASK
Publication
E0973r ELISA Agtr2,Angiotensin II type-2 receptor,AT2,Rat,Rattus norvegicus,Type-2 angiotensin II receptor EIAab 96T 845 E0973r ELISA Agtr2,Angiotensin II type-2 receptor,AT2,Rat,Rattus norvegicus,Type-2 angiotensin II receptor EIAab 96T 845 Publication
M1579 pCAMBIA0105.1R Vector, (GusPlus™ No Bacterial Selection Streptomycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker for adding DNA of intere MarkerGene 186 M1579 pCAMBIA0105.1R Vector, (GusPlus™ No Bacterial Selection Streptomycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker for adding DNA of intere MarkerGene 186
ASK
Publication
M1395 pDC99 Mammalian Luciferase Expression Vector, This vector is very useful for transfection of mammalian cells in culture and may also be used in other species, 20 micrograms MarkerGene 361 M1395 pDC99 Mammalian Luciferase Expression Vector, This vector is very useful for transfection of mammalian cells in culture and may also be used in other species, 20 micrograms MarkerGene 361
ASK
Publication
M1394 pDC57 Mammalian Luciferase Expression Vector, This vector is very useful for transfection of mammalian cells in culture and may also be used in other species, 20 micrograms MarkerGene 361 M1394 pDC57 Mammalian Luciferase Expression Vector, This vector is very useful for transfection of mammalian cells in culture and may also be used in other species, 20 micrograms MarkerGene 361
ASK
Publication
M1587 pCAMBIA1105.1R Vecotr (GusPlus™ Hygromycin B Streptomycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, Hygromycin B resistance gene, stre MarkerGene 186 M1587 pCAMBIA1105.1R Vecotr (GusPlus™ Hygromycin B Streptomycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, Hygromycin B resistance gene, stre MarkerGene 186
ASK
Publication
AA0108 Growth Factor (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 human growth factors in 8-10 samples. Abnova 16 Arrays/Slide 1764 AA0108 Growth Factor (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 human growth factors in 8-10 samples. Abnova 16 Arrays/Slide 1764
ASK
Publication
M1588 pCAMBIA1200 Vector (No Reporter Gene Hygromycin B chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, Hygromycin B and chloramph MarkerGene 186 M1588 pCAMBIA1200 Vector (No Reporter Gene Hygromycin B chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, Hygromycin B and chloramph MarkerGene 186
ASK
Publication
M1307 pCMVLuxB Mammalian LuxB Expression Vector, High copy number eukaryotic vector, pCMVLuxB, expresses the beta subunit of luciferase encoded by the bacterium Vibria harveyi. When paired with pCMVLuxA, l MarkerGene 197 M1307 pCMVLuxB Mammalian LuxB Expression Vector, High copy number eukaryotic vector, pCMVLuxB, expresses the beta subunit of luciferase encoded by the bacterium Vibria harveyi. When paired with pCMVLuxA, l MarkerGene 197
ASK
Publication
M1306 pCMVLuxA Mammalian LuxA Expression Vector, High copy number eukaryotic vector, pCMVLuxA, expresses the alpha subunit of luciferase encoded by the bacterium Vibria harveyi. When paired with pCMVLuxB, MarkerGene 197 M1306 pCMVLuxA Mammalian LuxA Expression Vector, High copy number eukaryotic vector, pCMVLuxA, expresses the alpha subunit of luciferase encoded by the bacterium Vibria harveyi. When paired with pCMVLuxB, MarkerGene 197
ASK
Publication
M1597 pCAMBIA1305.2 Vector (Secretory GusPlus™ Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B r MarkerGene 186 M1597 pCAMBIA1305.2 Vector (Secretory GusPlus™ Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B r MarkerGene 186
ASK
Publication
M1596 pCAMBIA1305.1 Vector (GusPlus™ Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186 M1596 pCAMBIA1305.1 Vector (GusPlus™ Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186
ASK
Publication
M1590 pCAMBIA1281Z Vector (gusA lacZ Hygromycin B Chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, Hygromycin B and chloramphenicol MarkerGene 186 M1590 pCAMBIA1281Z Vector (gusA lacZ Hygromycin B Chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, Hygromycin B and chloramphenicol MarkerGene 186
ASK
Publication
M1589 pCAMBIA1201 Vector (gusA Hygromycin B Chloramphenicol Resistant Plant Expression Vector), Restriction sites or modular plasmid modifications, pUC18 poly-linker, Hygromycin B and chloramphenicol resist MarkerGene 186 M1589 pCAMBIA1201 Vector (gusA Hygromycin B Chloramphenicol Resistant Plant Expression Vector), Restriction sites or modular plasmid modifications, pUC18 poly-linker, Hygromycin B and chloramphenicol resist MarkerGene 186
ASK
Publication
M1708 pCAMBIA2200 Vector (No Reporter Gene Kanamycin Chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and chloramphenicol MarkerGene 186 M1708 pCAMBIA2200 Vector (No Reporter Gene Kanamycin Chloramphenicol Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and chloramphenicol MarkerGene 186
ASK
Publication
M1592 pCAMBIA1301 Vector (gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance genes, MarkerGene 186 M1592 pCAMBIA1301 Vector (gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance genes, MarkerGene 186
ASK
Publication
M1591 pCAMBIA1300 Vector (No Reporter Gene Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resis MarkerGene 186 M1591 pCAMBIA1300 Vector (No Reporter Gene Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resis MarkerGene 186 Publication
M1584 pCAMBIA0390 Vector (No Reporter, No Bacterial Selection Kanamycin Resistant pUC9 Plant Expression Vector), Has restriction sites for modular plasmid modifications, pUC9 poly-linker, Kanamycin resistan MarkerGene 186 M1584 pCAMBIA0390 Vector (No Reporter, No Bacterial Selection Kanamycin Resistant pUC9 Plant Expression Vector), Has restriction sites for modular plasmid modifications, pUC9 poly-linker, Kanamycin resistan MarkerGene 186
ASK
Publication
M1595 pCAMBIA1304 Vector (gusA mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186 M1595 pCAMBIA1304 Vector (gusA mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186
ASK
Publication
M1710 pCAMBIA2301 Vector (gusA Kanamycin Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, genes for bacterial and plant selection with ka MarkerGene 186 M1710 pCAMBIA2301 Vector (gusA Kanamycin Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, genes for bacterial and plant selection with ka MarkerGene 186
ASK
Publication
M1594 pCAMBIA1303 Vector (mgfp5 gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186 M1594 pCAMBIA1303 Vector (mgfp5 gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186
ASK
Publication
M1593 pCAMBIA1302 Vector (mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, mgfp MarkerGene 186 M1593 pCAMBIA1302 Vector (mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, mgfp MarkerGene 186
ASK
Publication
M1704 pCAMBIA1391 Vector (gusA Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC9 poly-linker, kanamycin and hygromycin B resistance, g MarkerGene 186 M1704 pCAMBIA1391 Vector (gusA Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC9 poly-linker, kanamycin and hygromycin B resistance, g MarkerGene 186
ASK
Publication
M1703 pCAMBIA1390 Vector (No Reporter Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), Restriction sites for modular plasmid modifications,pUC9 poly-linker, kanamycin and hygromycin B resista MarkerGene 186 M1703 pCAMBIA1390 Vector (No Reporter Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), Restriction sites for modular plasmid modifications,pUC9 poly-linker, kanamycin and hygromycin B resista MarkerGene 186
ASK
Publication
M1598 pCAMBIA1380 Vector (No Reporter Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, kanamycin and hygromycin B resist MarkerGene 186 M1598 pCAMBIA1380 Vector (No Reporter Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, kanamycin and hygromycin B resist MarkerGene 186
ASK
Publication
M1702 pCAMBIA1381Z Vector (gusA lacZ Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, kanamycin and hygromycin B resist MarkerGene 186 M1702 pCAMBIA1381Z Vector (gusA lacZ Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC8 poly-linker, kanamycin and hygromycin B resist MarkerGene 186
ASK
Publication
0801519 PSEUDOMONAS AERUGINOSA clinical isolate, titered Zeptometrix 0 0801519 PSEUDOMONAS AERUGINOSA clinical isolate, titered Zeptometrix 0
ASK
Publication
0801517 ESCHERICHIA COLI clinical isolate, titered Zeptometrix ML 476 0801517 ESCHERICHIA COLI clinical isolate, titered Zeptometrix ML 476
ASK
Publication
0801650 CAMPYLOBACTER JEJUNI clinical isolate, titered Zeptometrix 0 0801650 CAMPYLOBACTER JEJUNI clinical isolate, titered Zeptometrix 0
ASK
Publication
RD191001100 ELISA Human , Leptin , Clinical Range Biovendor 96 wells (1 kit) 241 RD191001100 ELISA Human , Leptin , Clinical Range Biovendor 96 wells (1 kit) 241
ASK
Publication
0801650 BACTERIOLOGY CAMPYLOBACTER JEJUNI clinical isolate, titered Zeptometrix 1 0 0801650 BACTERIOLOGY CAMPYLOBACTER JEJUNI clinical isolate, titered Zeptometrix 1 0
ASK
Publication
0801519 BACTERIOLOGY PSEUDOMONAS AERUGINOSA clinical isolate, titered Zeptometrix 1 0 0801519 BACTERIOLOGY PSEUDOMONAS AERUGINOSA clinical isolate, titered Zeptometrix 1 0
ASK
Publication
M1705 pCAMBIA1391Xa Vector (Fusible gusA (ORFa)Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fusi MarkerGene 186 M1705 pCAMBIA1391Xa Vector (Fusible gusA (ORFa)Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fusi MarkerGene 186
ASK
Publication
M1582 pCAMBIA0305.2 Vector (Secreted GusPlus™No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance, GusPlus™, GRP signal pepti MarkerGene 186 M1582 pCAMBIA0305.2 Vector (Secreted GusPlus™No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance, GusPlus™, GRP signal pepti MarkerGene 186
ASK
Publication
M1701 pCAMBIA1381Xc Vector (Fusible gusA(ORF c)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA no start codon to allow fusion of MarkerGene 186 M1701 pCAMBIA1381Xc Vector (Fusible gusA(ORF c)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA no start codon to allow fusion of MarkerGene 186
ASK
Publication
M1700 pCAMBIA1381Xb Vector (Fusible gusA(ORF b)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion of MarkerGene 186 M1700 pCAMBIA1381Xb Vector (Fusible gusA(ORF b)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion of MarkerGene 186
ASK
Publication
M1599 pCAMBIA1381Xa Vector (Fusible gusA(ORF a)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion of MarkerGene 186 M1599 pCAMBIA1381Xa Vector (Fusible gusA(ORF a)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion of MarkerGene 186
ASK
Publication
M1707 pCAMBIA1391Z Vector (gusA lacZ Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA, lacZ gene for white blue selection, 20UG MarkerGene 186 M1707 pCAMBIA1391Z Vector (gusA lacZ Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA, lacZ gene for white blue selection, 20UG MarkerGene 186
ASK
Publication
M1706 pCAMBIA1391Xc Vector (Fusible gusA (ORF c) Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fu MarkerGene 186 M1706 pCAMBIA1391Xc Vector (Fusible gusA (ORF c) Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fu MarkerGene 186
ASK
Publication
ME483 Melanoma tissue array, including TNM and clinical stage, 48 cases 48 cores US Biomax 231 ME483 Melanoma tissue array, including TNM and clinical stage, 48 cases 48 cores US Biomax 231
ASK
Publication
ME2082 Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores US Biomax 456 ME2082 Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores US Biomax 456
ASK
Publication
M1709 pCAMBIA2300 Vector (No Reporter Gene Kanamycin Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, genes for bacterial and plant selection with kanamycin, no reporter gene allowing constr MarkerGene 186 M1709 pCAMBIA2300 Vector (No Reporter Gene Kanamycin Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, genes for bacterial and plant selection with kanamycin, no reporter gene allowing constr MarkerGene 186
ASK
Publication
OV1501 Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores US Biomax 231 OV1501 Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases 150 cores US Biomax 231
ASK
Publication
FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167
ASK
Publication
FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167
ASK
Publication
LC727 Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores US Biomax 231 LC727 Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores US Biomax 231
ASK
Publication
ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266 ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266
ASK
Publication
LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331 FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331
ASK
Publication
LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
TH721 Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores US Biomax 266 TH721 Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores US Biomax 266
ASK
Publication
UT721 Endometrioid adenocarcinoma and normal tissue array with clinical stage and grade information, 24 cases 72 cores US Biomax 266 UT721 Endometrioid adenocarcinoma and normal tissue array with clinical stage and grade information, 24 cases 72 cores US Biomax 266
ASK
Publication
CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231 CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231
ASK
Publication
CR1002 Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 CR1002 Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV1201 Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 397 LV1201 Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 397
ASK
Publication
KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
ST1002 Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 ST1002 Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231 MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231
ASK
Publication
OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 US Biomax 781 FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 US Biomax 781
ASK
Publication
KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores US Biomax 231 BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores US Biomax 231
ASK
Publication
RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231
ASK
Publication
BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516 LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516
ASK
Publication
MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456 MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266 BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266
ASK
Publication
BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516 MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516
ASK
Publication
OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC000120 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 BC000120 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456
ASK
Publication
LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266 BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266
ASK
Publication
CO1003 Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 CO1003 Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
FMC406 Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores US Biomax 167 FMC406 Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores US Biomax 167
ASK
Publication
LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266 BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266
ASK
Publication
PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278 PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278
ASK
Publication
CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC000119 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 BC000119 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456
ASK
Publication
LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
Y102528 Dengue Type 2 ABM Goods 100 ul 501 Y102528 Dengue Type 2 ABM Goods 100 ul 501
ASK
Publication
Y102530 Dengue Type 4 ABM Goods 100 ul 501 Y102530 Dengue Type 4 ABM Goods 100 ul 501
ASK
Publication
Y102527 Dengue Type 1 ABM Goods 100 ul 501 Y102527 Dengue Type 1 ABM Goods 100 ul 501
ASK
Publication
Y102529 Dengue Type 3 ABM Goods 100 ul 501 Y102529 Dengue Type 3 ABM Goods 100 ul 501
ASK
Publication
M1581 pCAMBIA0305.1 Vector, (GusPlus™ No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance gene, GusPlus™ reporter gene, 20UG MarkerGene 186 M1581 pCAMBIA0305.1 Vector, (GusPlus™ No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance gene, GusPlus™ reporter gene, 20UG MarkerGene 186
ASK
Publication
BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266 BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266
ASK
Publication
OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores US Biomax 231 LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores US Biomax 231
ASK
Publication
ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266
ASK
Publication
KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88 BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88
ASK
Publication
BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores US Biomax 231 BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores US Biomax 231
ASK
Publication
ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 US Biomax 88 BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 US Biomax 88
ASK
Publication
BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397 BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397
ASK
Publication
OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a US Biomax 293 FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a US Biomax 293
ASK
Publication
CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266
ASK
Publication
CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397 CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 US Biomax 231 LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 US Biomax 231
ASK
Publication
OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
Y102528 Dengue Type 2 Antibody ABM Goods 100 ul 447 Y102528 Dengue Type 2 Antibody ABM Goods 100 ul 447
ASK
Publication
Y104128 Dengue Type 1 ABM Goods 100ul 501 Y104128 Dengue Type 1 ABM Goods 100ul 501
ASK
Publication
Y108211 Angiotensin II Type 1 (AT1), Rat ABM Goods 100ug 1168.65 Y108211 Angiotensin II Type 1 (AT1), Rat ABM Goods 100ug 1168.65
ASK
Publication
Y102530 Dengue Type 4 Antibody ABM Goods 100 ul 447 Y102530 Dengue Type 4 Antibody ABM Goods 100 ul 447
ASK
Publication
Y104130 Dengue Type 3 ABM Goods 100ul 501 Y104130 Dengue Type 3 ABM Goods 100ul 501
ASK
Publication
Y102527 Dengue Type 1 Antibody ABM Goods 100 ul 447 Y102527 Dengue Type 1 Antibody ABM Goods 100 ul 447
ASK
Publication
Y108203 Angiotensin II Type 1 (AT1), Rat ABM Goods 100ug 1168.65 Y108203 Angiotensin II Type 1 (AT1), Rat ABM Goods 100ug 1168.65
ASK
Publication
Y102529 Dengue Type 3 Antibody ABM Goods 100 ul 447 Y102529 Dengue Type 3 Antibody ABM Goods 100 ul 447
ASK
Publication
Y104129 Dengue Type 2 ABM Goods 100ul 501 Y104129 Dengue Type 2 ABM Goods 100ul 501
ASK
Publication
0810047 Enterovirus Type 71 Lysate Zeptometrix MG 1489 0810047 Enterovirus Type 71 Lysate Zeptometrix MG 1489
ASK
Publication
Y104131 Dengue Type 4 ABM Goods 100ul 501 Y104131 Dengue Type 4 ABM Goods 100ul 501
ASK
Publication
SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266
ASK
Publication
LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753 LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753
ASK
Publication
BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429 ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429
ASK
Publication
BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LC1008 Non small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 LC1008 Non small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC001130 Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores US Biomax 278 BC001130 Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores US Biomax 278
ASK
Publication
ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231 ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231
ASK
Publication
UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296 EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162 PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267 SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456 BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456
ASK
Publication
RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231 BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231
ASK
Publication
T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b US Biomax 231 BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b US Biomax 231
ASK
Publication
LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
IRPAI-1mg Rat PAI-1 (wild type active form) 1mg Innovative Research INC 1571 IRPAI-1mg Rat PAI-1 (wild type active form) 1mg Innovative Research INC 1571
ASK
Publication
Y108211 Angiotensin II Type 1 (AT1), Rat Antibody ABM Goods 100ug 1035.3 Y108211 Angiotensin II Type 1 (AT1), Rat Antibody ABM Goods 100ug 1035.3
ASK
Publication
228-10316-1 Recombinant Dengue Virus NS1 n-end Type 2 Ray Biotech 100 343 228-10316-1 Recombinant Dengue Virus NS1 n-end Type 2 Ray Biotech 100 343 Publication
Y050912 Anti-Dengue Type 2 Antibody ABM Goods 100μg 550 Y050912 Anti-Dengue Type 2 Antibody ABM Goods 100μg 550
ASK
Publication
20041 Immunization grade rat type II collagen, 5 mg Chondrex 333.9 20041 Immunization grade rat type II collagen, 5 mg Chondrex 333.9
ASK
Publication
IGLYHPAI-A-1mg Human PAI-1 (glycosylated wild type) 1mg Innovative Research INC 1805 IGLYHPAI-A-1mg Human PAI-1 (glycosylated wild type) 1mg Innovative Research INC 1805 Publication
Y104130 Dengue Type 3 Antibody ABM Goods 100ul 447 Y104130 Dengue Type 3 Antibody ABM Goods 100ul 447
ASK
Publication
IRPAI-0.5mg Rat PAI-1 (wild type active form) 0.5mg Innovative Research INC 980 IRPAI-0.5mg Rat PAI-1 (wild type active form) 0.5mg Innovative Research INC 980
ASK
Publication
228-10712-2 Recombinant HIV Type-O Envelope Proteins Ray Biotech 500 601 228-10712-2 Recombinant HIV Type-O Envelope Proteins Ray Biotech 500 601
ASK
Publication
IGLYHPAI-A-0.5mg Human PAI-1 (glycosylated wild type) 0.5mg Innovative Research INC 1162 IGLYHPAI-A-0.5mg Human PAI-1 (glycosylated wild type) 0.5mg Innovative Research INC 1162
ASK
Publication
RSHAKRIN010HR ELISA Insulin (H-type) ,Rat Biovendor 96 wells (1 kit) 543 RSHAKRIN010HR ELISA Insulin (H-type) ,Rat Biovendor 96 wells (1 kit) 543 Publication
6008 Human type I collagen detection kit Chondrex 483 6008 Human type I collagen detection kit Chondrex 483 Publication
Y108203 Angiotensin II Type 1 (AT1), Rat Antibody ABM Goods 100ug 1035.3 Y108203 Angiotensin II Type 1 (AT1), Rat Antibody ABM Goods 100ug 1035.3
ASK
Publication
228-10315-2 Recombinant Dengue Virus NS1 c-end Type 2 Ray Biotech 500 894 228-10315-2 Recombinant Dengue Virus NS1 c-end Type 2 Ray Biotech 500 894 Publication
MD-22-0013P Bovine Collagen Type IV Proteins Ray Biotech 500 485 MD-22-0013P Bovine Collagen Type IV Proteins Ray Biotech 500 485
ASK
Publication
Y212457 Arginase, type 1 arg1(rat) ABM Goods 200ul 520.8 Y212457 Arginase, type 1 arg1(rat) ABM Goods 200ul 520.8
ASK
Publication
228-10712-1 Recombinant HIV Type-O Envelope Proteins Ray Biotech 100 240 228-10712-1 Recombinant HIV Type-O Envelope Proteins Ray Biotech 100 240
ASK
Publication
1064 Immunization grade rat type I collagen, 5 mg Chondrex 220.5 1064 Immunization grade rat type I collagen, 5 mg Chondrex 220.5
ASK
Publication
Y104129 Dengue Type 2 Antibody ABM Goods 100ul 447 Y104129 Dengue Type 2 Antibody ABM Goods 100ul 447
ASK
Publication
228-10315-1 Recombinant Dengue Virus NS1 c-end Type 2 Ray Biotech 100 343 228-10315-1 Recombinant Dengue Virus NS1 c-end Type 2 Ray Biotech 100 343 Publication
cAP-17 Bovine Type I Collagen Solution AngoiPro 100.00 mg 215 cAP-17 Bovine Type I Collagen Solution AngoiPro 100.00 mg 215 Publication
IRPAI-L-1mg Rat PAI-1 (wild type latent form) 1mg Innovative Research INC 1571 IRPAI-L-1mg Rat PAI-1 (wild type latent form) 1mg Innovative Research INC 1571 Publication
1102 NC1 fragment of bovine GBM type IV collagen, 1 mg Chondrex 312.9 1102 NC1 fragment of bovine GBM type IV collagen, 1 mg Chondrex 312.9 Publication
RSHAKRIN130R ELISA Insulin (U-type) ,Rat Biovendor 96 wells (1 kit) 659 RSHAKRIN130R ELISA Insulin (U-type) ,Rat Biovendor 96 wells (1 kit) 659 Publication
228-10713-2 Recombinant HIV Type-O gp41 Proteins Ray Biotech 500 601 228-10713-2 Recombinant HIV Type-O gp41 Proteins Ray Biotech 500 601
ASK
Publication
Y104131 Dengue Type 4 Antibody ABM Goods 100ul 447 Y104131 Dengue Type 4 Antibody ABM Goods 100ul 447
ASK
Publication
1004 ELISA grade rat type I collagen, 0.5 mg Chondrex 155.4 1004 ELISA grade rat type I collagen, 0.5 mg Chondrex 155.4
ASK
Publication
IRPAI-L-0.5mg Rat PAI-1 (wild type latent form) 0.5mg Innovative Research INC 980 IRPAI-L-0.5mg Rat PAI-1 (wild type latent form) 0.5mg Innovative Research INC 980
ASK
Publication
Y212456 Arginase, type 1 ARG1 ABM Goods 200ul 520.8 Y212456 Arginase, type 1 ARG1 ABM Goods 200ul 520.8
ASK
Publication
228-10316-2 Recombinant Dengue Virus NS1 n-end Type 2 Ray Biotech 500 894 228-10316-2 Recombinant Dengue Virus NS1 n-end Type 2 Ray Biotech 500 894 Publication
Y104128 Dengue Type 1 Antibody ABM Goods 100ul 447 Y104128 Dengue Type 1 Antibody ABM Goods 100ul 447
ASK
Publication
228-10713-1 Recombinant HIV Type-O gp41 Proteins Ray Biotech 100 240 228-10713-1 Recombinant HIV Type-O gp41 Proteins Ray Biotech 100 240
ASK
Publication
cAP-06 Rat Tail Type I Collagen Solution AngoiPro 100.00 mg 215 cAP-06 Rat Tail Type I Collagen Solution AngoiPro 100.00 mg 215 Publication
BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267 TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90 T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626 FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 US Biomax 231 LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 US Biomax 231
ASK
Publication
HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266 HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266
ASK
Publication
OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456 OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456
ASK
Publication
20011 Immunization grade chick type II collagen, 10 mg Chondrex 232.05 20011 Immunization grade chick type II collagen, 10 mg Chondrex 232.05
ASK
Publication
1062 Immunization grade bovine type I collagen, 10 mg Chondrex 169.05 1062 Immunization grade bovine type I collagen, 10 mg Chondrex 169.05
ASK
Publication
1024 ELRGRI Rat IgG anti rat type I collagen ELISA kit Chondrex 464.1 1024 ELRGRI Rat IgG anti rat type I collagen ELISA kit Chondrex 464.1
ASK
Publication
RSHAKRIN011HR ELISA Insulin (H-type) ,Mouse Biovendor 96 wells (1 kit) 563 RSHAKRIN011HR ELISA Insulin (H-type) ,Mouse Biovendor 96 wells (1 kit) 563 Publication
228-10244-2 Recombinant Human CKMB Type-2 Proteins Ray Biotech 50 292 228-10244-2 Recombinant Human CKMB Type-2 Proteins Ray Biotech 50 292
ASK
Publication
128-10064-1 Mouse Anti-Dengue Type 2 (envelope) Ray Biotech 500 343 128-10064-1 Mouse Anti-Dengue Type 2 (envelope) Ray Biotech 500 343
ASK
Publication
CYT-327 Recombinant Human B type Natriuretic Protein Prospecbio 2µg 96 CYT-327 Recombinant Human B type Natriuretic Protein Prospecbio 2µg 96
ASK
Publication
YV0082-2 Herpesvirus Type 1 (BHV 1 IBR), Goat anti Bovine, Accurate 2 ml. 230 YV0082-2 Herpesvirus Type 1 (BHV 1 IBR), Goat anti Bovine, Accurate 2 ml. 230 Publication
228-10712-3 Recombinant HIV Type-O Envelope Proteins Ray Biotech 1000 1031 228-10712-3 Recombinant HIV Type-O Envelope Proteins Ray Biotech 1000 1031
ASK
Publication
228-11249-1 Recombinant PKA holoenzyme, type 1 alpha Proteins Ray Biotech 1 147 228-11249-1 Recombinant PKA holoenzyme, type 1 alpha Proteins Ray Biotech 1 147
ASK
Publication
1001 ELISA grade chick type I collagen, 0.5 mg Chondrex 130.2 1001 ELISA grade chick type I collagen, 0.5 mg Chondrex 130.2
ASK
Publication
IMPAI-L-0.5mg Mouse PAI-1 (wild type latent form) 0.5mg Innovative Research INC 863 IMPAI-L-0.5mg Mouse PAI-1 (wild type latent form) 0.5mg Innovative Research INC 863
ASK
Publication
1075 Immunization grade human type IX collagen, 1 mg Chondrex 563.85 1075 Immunization grade human type IX collagen, 1 mg Chondrex 563.85
ASK
Publication
228-10247-1 Recombinant Human CKMM Type-3 Proteins Ray Biotech 10 147 228-10247-1 Recombinant Human CKMM Type-3 Proteins Ray Biotech 10 147
ASK
Publication
228-10714-2 Recombinant HIV Type-O gp41 [MBP-fusion] Proteins Ray Biotech 500 485 228-10714-2 Recombinant HIV Type-O gp41 [MBP-fusion] Proteins Ray Biotech 500 485
ASK
Publication
20031 Immunization grade porcine type II collagen, 10 mg Chondrex 232.05 20031 Immunization grade porcine type II collagen, 10 mg Chondrex 232.05
ASK
Publication
228-11250-3 Recombinant PKA holoenzyme, type 2 alpha Proteins Ray Biotech 100 0 228-11250-3 Recombinant PKA holoenzyme, type 2 alpha Proteins Ray Biotech 100 0
ASK
Publication
1082 Immunization grade bovine type XI collagen, 5 mg Chondrex 276.15 1082 Immunization grade bovine type XI collagen, 5 mg Chondrex 276.15
ASK
Publication
1085 Immunization grade human type XI collagen, 1 mg Chondrex 344.4 1085 Immunization grade human type XI collagen, 1 mg Chondrex 344.4
ASK
Publication
2014 ELRII ELISA grade rat type II collagen, 0.5 mg Chondrex 297.15 2014 ELRII ELISA grade rat type II collagen, 0.5 mg Chondrex 297.15
ASK
Publication
228-10315-3 Recombinant Dengue Virus NS1 c-end Type 2 Ray Biotech 1000 1551 228-10315-3 Recombinant Dengue Virus NS1 c-end Type 2 Ray Biotech 1000 1551 Publication
1072 Immunization grade bovine type IX collagen, 5 mg Chondrex 402.15 1072 Immunization grade bovine type IX collagen, 5 mg Chondrex 402.15
ASK
Publication
1006 ELISA grade mouse type I collagen, 0.5 mg Chondrex 155.4 1006 ELISA grade mouse type I collagen, 0.5 mg Chondrex 155.4
ASK
Publication
228-10244-1 Recombinant Human CKMB Type-2 Proteins Ray Biotech 10 205 228-10244-1 Recombinant Human CKMB Type-2 Proteins Ray Biotech 10 205
ASK
Publication
Y212457 Arginase, type 1 arg1(rat) Antibody ABM Goods 200ul 462 Y212457 Arginase, type 1 arg1(rat) Antibody ABM Goods 200ul 462
ASK
Publication
DS-PB-01378 Goat Anti-Human MSR Type I Antibodies Ray Biotech 20 196 DS-PB-01378 Goat Anti-Human MSR Type I Antibodies Ray Biotech 20 196
ASK
Publication
IMPAI-1mg Mouse PAI-1 (wild type active form) 1mg Innovative Research INC 1571 IMPAI-1mg Mouse PAI-1 (wild type active form) 1mg Innovative Research INC 1571 Publication
228-10246-3 Recombinant Human CKMM Type-1 Proteins Ray Biotech 1mg 997 228-10246-3 Recombinant Human CKMM Type-1 Proteins Ray Biotech 1mg 997
ASK
Publication
228-10714-1 Recombinant HIV Type-O gp41 [MBP-fusion] Proteins Ray Biotech 100 353 228-10714-1 Recombinant HIV Type-O gp41 [MBP-fusion] Proteins Ray Biotech 100 353
ASK
Publication
228-11250-2 Recombinant PKA holoenzyme, type 2 alpha Proteins Ray Biotech 3 485 228-11250-2 Recombinant PKA holoenzyme, type 2 alpha Proteins Ray Biotech 3 485
ASK
Publication
1003 ELISA grade porcine type I collagen, 0.5 mg Chondrex 130.2 1003 ELISA grade porcine type I collagen, 0.5 mg Chondrex 130.2
ASK
Publication
2014 ELRII ELISA grade rat type II collagen Chondrex 0.5 mg 238.35 2014 ELRII ELISA grade rat type II collagen Chondrex 0.5 mg 238.35
ASK
Publication
1061 Immunization grade chick type I collagen, 10 mg Chondrex 169.05 1061 Immunization grade chick type I collagen, 10 mg Chondrex 169.05
ASK
Publication
1004 ELRI ELISA grade rat type I collagen, 0.5 mg Chondrex 187.95 1004 ELRI ELISA grade rat type I collagen, 0.5 mg Chondrex 187.95
ASK
Publication
20061 Immunization grade mouse type II collagen, 1 mg Chondrex 203.7 20061 Immunization grade mouse type II collagen, 1 mg Chondrex 203.7
ASK
Publication
cAP-18 Bovine Type I Collagen based Hydrogel AngoiPro 50.00 ml 215 cAP-18 Bovine Type I Collagen based Hydrogel AngoiPro 50.00 ml 215 Publication
IRbPAI-L-1mg Rabbit PAI-1 (wild type latent form) 1mg Innovative Research INC 1571 IRbPAI-L-1mg Rabbit PAI-1 (wild type latent form) 1mg Innovative Research INC 1571 Publication
20081 Immunization grade sheep type II collagen, 5 mg Chondrex 252 20081 Immunization grade sheep type II collagen, 5 mg Chondrex 252
ASK
Publication
228-10243-3 Recombinant Human CKMB Type-1 Proteins Ray Biotech 1mg 997 228-10243-3 Recombinant Human CKMB Type-1 Proteins Ray Biotech 1mg 997
ASK
Publication
1106 NC1 fragment of mouse renal type IV collagen, 1 mg Chondrex 332.85 1106 NC1 fragment of mouse renal type IV collagen, 1 mg Chondrex 332.85
ASK
Publication
1054 T-cell proliferation grade rat type I collagen, 0.5 mg Chondrex 151.2 1054 T-cell proliferation grade rat type I collagen, 0.5 mg Chondrex 151.2
ASK
Publication
DS-PB-01377 Goat Anti-Human MSR Type I Antibodies Ray Biotech 0.1 ml 411 DS-PB-01377 Goat Anti-Human MSR Type I Antibodies Ray Biotech 0.1 ml 411
ASK
Publication
20042 Immunization grade rat type II collagen, 5 mg solution Chondrex 333.9 20042 Immunization grade rat type II collagen, 5 mg solution Chondrex 333.9
ASK
Publication
IMPAI-0.5mg Mouse PAI-1 (wild type active form) 0.5mg Innovative Research INC 863 IMPAI-0.5mg Mouse PAI-1 (wild type active form) 0.5mg Innovative Research INC 863
ASK
Publication
228-10246-2 Recombinant Human CKMM Type-1 Proteins Ray Biotech 50 205 228-10246-2 Recombinant Human CKMM Type-1 Proteins Ray Biotech 50 205
ASK
Publication
228-10713-3 Recombinant HIV Type-O gp41 Proteins Ray Biotech 1000 1244 228-10713-3 Recombinant HIV Type-O gp41 Proteins Ray Biotech 1000 1244
ASK
Publication
2044T Rat anti-rat type II collagen IgG antibody assay kit, TMB Chondrex 434.7 2044T Rat anti-rat type II collagen IgG antibody assay kit, TMB Chondrex 434.7
ASK
Publication
1065 Immunization grade human type I collagen, 1 mg Chondrex 307.65 1065 Immunization grade human type I collagen, 1 mg Chondrex 307.65
ASK
Publication
228-11250-1 Recombinant PKA holoenzyme, type 2 alpha Proteins Ray Biotech 1 205 228-11250-1 Recombinant PKA holoenzyme, type 2 alpha Proteins Ray Biotech 1 205
ASK
Publication
1002 ELISA grade bovine type I collagen, 0.5 mg Chondrex 130.2 1002 ELISA grade bovine type I collagen, 0.5 mg Chondrex 130.2
ASK
Publication
20051 Immunization grade human type II collagen, 1 mg Chondrex 349.65 20051 Immunization grade human type II collagen, 1 mg Chondrex 349.65
ASK
Publication
IPOPAI-1mg Porcine PAI-1 (wild type active form) 1mg Innovative Research INC 1571 IPOPAI-1mg Porcine PAI-1 (wild type active form) 1mg Innovative Research INC 1571 Publication
1083 Immunization grade porcine type XI collagen, 5 mg Chondrex 276.15 1083 Immunization grade porcine type XI collagen, 5 mg Chondrex 276.15
ASK
Publication
2014 ELISA grade rat type II collagen, 0.5 mg solution Chondrex 241.5 2014 ELISA grade rat type II collagen, 0.5 mg solution Chondrex 241.5
ASK
Publication
1004 ELRI ELISA grade rat type I collagen Chondrex 0.5 mg 164.85 1004 ELRI ELISA grade rat type I collagen Chondrex 0.5 mg 164.85
ASK
Publication
IRbPAI-L-0.5mg Rabbit PAI-1 (wild type latent form) 0.5mg Innovative Research INC 928 IRbPAI-L-0.5mg Rabbit PAI-1 (wild type latent form) 0.5mg Innovative Research INC 928
ASK
Publication
MD-14-1033 Rabbit Anti-Rat Collagen Type I Antibodies Ray Biotech 500 790 MD-14-1033 Rabbit Anti-Rat Collagen Type I Antibodies Ray Biotech 500 790
ASK
Publication
20071 Immmunization grade goat type II collagen, 5 mg Chondrex 252 20071 Immmunization grade goat type II collagen, 5 mg Chondrex 252
ASK
Publication
228-10243-2 Recombinant Human CKMB Type-1 Proteins Ray Biotech 50 205 228-10243-2 Recombinant Human CKMB Type-1 Proteins Ray Biotech 50 205
ASK
Publication
Y212456 Arginase, type 1 ARG1 Antibody ABM Goods 200ul 462 Y212456 Arginase, type 1 ARG1 Antibody ABM Goods 200ul 462
ASK
Publication
228-10316-3 Recombinant Dengue Virus NS1 n-end Type 2 Ray Biotech 1000 1551 228-10316-3 Recombinant Dengue Virus NS1 n-end Type 2 Ray Biotech 1000 1551 Publication
MD-05-0059 Rabbit Anti-C. botulinum Type A HA 33 Antibodies Ray Biotech 1 mg 1312 MD-05-0059 Rabbit Anti-C. botulinum Type A HA 33 Antibodies Ray Biotech 1 mg 1312 Publication
DS-MB-02710 Mouse Anti-Dengue Virus Type 2 Ray Biotech 100 755 DS-MB-02710 Mouse Anti-Dengue Virus Type 2 Ray Biotech 100 755
ASK
Publication
1024T Rat anti-rat type I collagen IgG antibody assay kit, TMB Chondrex 373.8 1024T Rat anti-rat type I collagen IgG antibody assay kit, TMB Chondrex 373.8
ASK
Publication
2024 T-cell proliferation grade rat type II collagen, 0.5 mg Chondrex 241.5 2024 T-cell proliferation grade rat type II collagen, 0.5 mg Chondrex 241.5
ASK
Publication
1073 Immunization grade porcine type IX collagen, 5 mg Chondrex 325.5 1073 Immunization grade porcine type IX collagen, 5 mg Chondrex 325.5
ASK
Publication
228-10246-1 Recombinant Human CKMM Type-1 Proteins Ray Biotech 10 147 228-10246-1 Recombinant Human CKMM Type-1 Proteins Ray Biotech 10 147
ASK
Publication
2044 Rat anti-rat type II collagen IgG antibody assay kit, OPD Chondrex 434.7 2044 Rat anti-rat type II collagen IgG antibody assay kit, OPD Chondrex 434.7
ASK
Publication
IGLYHPAI-L-1mg Human PAI-1 (glycosylated wild type latent) 1mg Innovative Research INC 1805 IGLYHPAI-L-1mg Human PAI-1 (glycosylated wild type latent) 1mg Innovative Research INC 1805 Publication
228-11249-3 Recombinant PKA holoenzyme, type 1 alpha Proteins Ray Biotech 100 0 228-11249-3 Recombinant PKA holoenzyme, type 1 alpha Proteins Ray Biotech 100 0
ASK
Publication
IPOPAI-0.5mg Porcine PAI-1 (wild type active form) 0.5mg Innovative Research INC 928 IPOPAI-0.5mg Porcine PAI-1 (wild type active form) 0.5mg Innovative Research INC 928
ASK
Publication
1081 Immunization grade chick type XI collagen, 5 mg Chondrex 276.15 1081 Immunization grade chick type XI collagen, 5 mg Chondrex 276.15
ASK
Publication
228-10247-3 Recombinant Human CKMM Type-3 Proteins Ray Biotech 1mg 997 228-10247-3